When: Wednesday, 10 November 2021

Where:  Virtual
                    In-person at The Hilton Niagara Falls Hotel
 1:00PM to 2:30PM


Vaccination throughout life is a key pillar of expanded prevention strategies that can save millions of lives and is a central component of universal health coverage. The collective voice and actions of public health professional, patient and advocacy organizations at and beyond the conference is required to ensure existing vaccine uptake targets are met and we strive for parity of such targets across the life course.


One of the single most important barriers to fulfilling this mandate is the lack of a joined-up approach and mechanism to mobilize information, experts and activists around a common agenda across disciplines and sectors. This conference acts as a bridge across disciplines and sectors with attention to patient and advocacy organizations.

Register now


Dr Mine Durusu Tanriover
MD, Prof. Internal Medicine

Hacettepe University Vaccine Institute, Department of Immunization Policies, Ankara, Turkey

She graduated from Hacettepe University Faculty of Medicine in 2000 and finished her residency training in internal medicine in 2005 in the same university. She has been serving as the consultant of the Acute Care Unit for several years, mainly admitting patients from the emergency department with acute decompensation of chronic diseases; lower respiratory tract infections, organ failure and acute, undiagnosed conditions.

Dr. Durusu Tanriover worked as the Co-Chief of Hacettepe University Oncology Hospital and the Quality Coordinator of Hacettepe University Hospitals, a Joint Commission International accredited, 1200-bed academic medical center between 2016-2020. Her research area mainly consists of adult vaccination, quality improvement, patient safety and chronic disease management. She has been involved in the Global Influenza Hospital Surveillance Network project as an investigator and site coordinator since 2012 and participated as a subinvestigator in the phase 3 clinical trials of COVID-19 vaccines available in Turkey. She is the author of more than 50 peer-reviewed articles.

Representing the Turkish Society of Internal Medicine, she is a member of the National Adult Immunization Guideline Task Force and Medical Specialty Council Curriculum Preparation Task Force. She is the founder and the first chair of the Young Internists Working Group and honorary fellow of the European Federation of Internal Medicine (EFIM). She is a member of the Quality and Professional Issues and the Adult Vaccination (ADVICE) Working Groups of EFIM. Dr. Durusu Tanriover is currently the Secretary of the Middle East, Eurasia and Africa Influenza Stakeholders Network.

Walter Ricciardi

Professor of Hygiene and Public Health at Università Cattolica del Sacro Cuore, Rome

  • Scientific Advisor to the Italian Minister of Health for the coronavirus pandemia.
  • Scientific Director of Istituti Clinici Scientifici Maugeri
  • President of the World Federation of Public Health Associations (WFPHA).
  • President of Mission Board for Cancer of European Commission.
  • Coordinator of the Scientific Advisory Board of Human Technopole Foundation.
  • Member of the Scientific Advisory Board of the Pan-European Commission on Health and
  • Sustainable Development: Rethinking policy priorities in the light of pandemics – World Health Organization – Regional Office for Europe.
  • Principal Investigator of EC Grant “TO REACH” the first health services and health systems research programme funded by European Commission (since 2016).
  • Ordinary Member of Pontificia Academia pro Vita, Vatican.
  • Italian Representative in the Executive Board of World Health Organisation (November 2017-May 2020).
  • Head of Department of Woman and Child Health and Public Health of Fondazione Policlinico Universitario Agostino Gemelli IRCCS – Università Cattolica del Sacro Cuore (from January to December 2019).
  • Former President of Istituto Superiore di Sanità (Italian National Institute of Health) (2015-2018) and its Commissioner from July 2014 to July 2015.
  • Member of the Expert Panel on effective ways of investing in Health (European Commission, DG – SANTE) for two three-year mandates (2013-2019).
  • Executive Board Member of the National Board of Medical Examiners of the United States of America (NBME) (2009-2015).
  • President of European Public Health Association (EUPHA) (2010-2014); since 2014 he is Past President of EUPHA.
  • Member of the III Sezione del Consiglio Superiore di Sanità, Ministry of Health (December 2009 – July 2010) and its President (December 2010 – July 2014)
  • He manages several undergraduate and postgraduate teaching activities.
  • Editor of European Journal of Public Health, of Oxford Handbook of Public Health Practice and Founding Editor of Italian Journal of Public Health and of Epidemiology, Biostatistics and Public Health.
  • “Laurea Honoris Causa” at Thomas Jefferson University, Philadelphia, USA (2019).
    Appointed “Commendatore” of the Italian Republic by Decree of the President of the Republic 02 June 2017.

Dr Vincenza Snow


Senior Medical Director, US Medical and Scientific Affairs Policy Lead

Pfizer Vaccines

Dr. Snow is a board-certified general internist with over 20 years of clinical practice experience and special interests in adult immunization, evidence-based guideline development, and clinical policy.  She has served on many national committees and policy bodies such as the CDC ACIP Evidence-based Recommendations Work Group, the Institute of Medicine (IOM) Roundtable on Evidence-based Guidelines, the provider workgroup (former chair) of the CDC/AMA Adult Immunization and Influenza Summit, liaison to the US Preventive Services Task Force of the Agency for Healthcare Research and Quality and has authored many policy papers and clinical practice guidelines for internal medicine.

Dr Snow has been at Pfizer since 2010. Her current position is Senior Medical Director, US Medical and Scientific Affairs Policy Lead where she is the lead Pfizer medical liaison to the CDC, ACIP, and ACIP Work Groups for all approved Pfizer vaccines and those in the pipeline, including for the Pfizer BioNTech COVID vaccine.

Her academic affiliations include the Medical College of Pennsylvania where she served as volunteer faculty until 2003 and she was a Senior Fellow in the Jefferson School of Population Health until 2013. She was seeing patients one day a week at a free clinic for the uninsured in South Philadelphia until 2012.